Medicine and Dentistry
Meta-Analysis
100%
Adverse Drug Reaction
96%
Low and Middle Income Countries
59%
Diseases
47%
COVID-19
44%
Cross Sectional Study
44%
Brain Disease
44%
Multiple Chronic Conditions
44%
Adverse Event
41%
Treatment Effect
35%
Apoplexy
35%
Rheumatoid Arthritis
33%
Checklist
33%
Tuberculostatic Agent
33%
Dermatosis
33%
Drug Therapy
30%
Observational Study
25%
Stillbirth
24%
Epileptic Seizure
23%
Cohort Analysis
22%
Breast Cancer
22%
Strabismus
22%
Amblyopia
22%
Thermal Burn
22%
Genetic Variability
22%
Eye Movement Disorder
22%
Reproducibility
22%
Unlicensed Drug Use
22%
Neonatal Sepsis
22%
Juvenile Dermatomyositis
22%
Bereavement
22%
Symptom
21%
Prevalence
20%
Clinician
19%
Base
18%
Eye Movement
18%
Pharmacogenetic Testing
17%
Patient Participation
16%
Reproductive Medicine
16%
Awareness
16%
Liver Toxicity
16%
Outcome Assessment
16%
Odds Ratio
15%
Childbirth
15%
Visual Impairment
14%
Subgroup Analysis
14%
Injury
14%
Case-Control Study
14%
Hormone Therapy
14%
Bleeding
13%
Nursing and Health Professions
Meta Analysis
71%
Practice Guideline
61%
Rheumatoid Arthritis
44%
Health Service
40%
Cochrane Library
37%
Health Care Personnel
32%
Adverse Event
31%
Prevalence
24%
Data Extraction
23%
Surgical Extractor
22%
Base
22%
Dysarthria
22%
Adverse Drug Reaction
22%
Symptom
21%
Medline
18%
Clinical Practice
17%
Peer Review
14%
Physician
14%
Checklist
14%
Disease
13%
Cross-Sectional Study
11%
Electronic Prescribing
11%
Citation Analysis
11%
Pandemic
11%
Rheumatic Disease
11%
Public Health Service
11%
Adolescent
11%
Strabismus
11%
Pain Measurement
11%
Skin Carcinoma
11%
Secretory Otitis Media
11%
Therapeutic Drug Monitoring
11%
Ward
11%
Confidence Interval
11%
Juvenile Rheumatoid Arthritis
11%
Drug Therapy
11%
Transitional Care
11%
Bronchiolitis
11%
Eye Movement Disorder
11%
Ankylosing Spondylitis
11%
Musculoskeletal Disease
11%
Brain Injury
11%
Child Health Care
11%
Public Health Informatics
11%
Splinting
11%
Agents Acting on the Eye
11%
Injury
11%
Antirheumatic Agent
11%
Acute Appendicitis
11%
Spondylarthritis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
71%
Prevalence
39%
Adverse Event
35%
Cross-Sectional Study
33%
Rheumatoid Arthritis
33%
Cohort Study
32%
Base
25%
Disease
25%
Observational Study
23%
Crohn's Disease
22%
Breast Cancer
22%
Tuberculostatic Agent
22%
Pandemic
22%
Symptom
19%
Case-Control Study
14%
Prospective Cohort Study
13%
Genetic Disorder
12%
Bleeding
11%
Add on Therapy
11%
Amblyopia
11%
Bronchiolitis
11%
Topiramate
11%
Eye Movement Disorder
11%
Skin Carcinoma
11%
Infliximab
11%
Musculoskeletal Disease
11%
Actinic Keratosis
11%
Beta1a Interferon
11%
Biosimilar Agent
11%
Basal Cell Carcinoma
11%
Dexamethasone
11%
Focal Epilepsy
11%
Neoplasm
11%
Postinflammatory Hyperpigmentation
11%
Acyltransferase
11%
Hemosiderosis
11%
Therapeutic Drug Monitoring
11%
Rheumatic Disease
11%
Acute Appendicitis
11%
Electronic Prescribing
11%
Secretory Otitis Media
11%
Cleft Palate
11%
Spondylarthritis
11%
Clinical Trial
11%
Cystic Fibrosis
11%
Skin Disease
11%
Side Effect
11%
Hypothermia
11%
Hepatotoxicity
10%
Interferon Beta Serine
8%